Session 3: Pigmentary Disorders and Keloids

Session 3: Pigmentary Disorders and Keloids


339 East Avenue Suite 410 Rochester, New York 14604

Gender, Race & Color

English Site

Recorded Webinar


Course Overview


Join clinical experts, thought leaders, and advocates for a collaborative discussion on the issues of health disparities, structural racism, and medicine as we examine specific dermatologic diseases in a series of four free and open educational webinars.
Implicit bias and structural racism play a central role in the development of health care disparities. One of the critically important areas in medicine is the misdiagnosis of disease in people with darker skin types due to implicit bias and the lack of awareness among physicians in recognizing the disease pattern. Clinicians in primary care, emergency medicine, hospital medicine, surgery, pediatrics, and other medical specialties can deliver improved care if they can recognize and diagnose medical conditions based on skin findings in patients of color. This four-part series aims to improve diagnosis in people of color, describe pathogenesis and treatment of diseases, develop cultural competency, and impact change in health care policy so more is done to reduce racial bias in medical practice and medical research. Providing this education, in turn, will ultimately help reduce health disparities and improve the lives of underrepresented minority populations. 



Pigmentary disorders and keloids can be signs of systemic disease and can cause significant psychological impact and social ramifications. Panelists will discuss the breadth of pigmentary disorders, including vitiligo, melasma, and post-inflammatory hyperpigmentation, and utilize global scientific literature to update the audience on newer therapeutic options.

Upon completion of this webinar you will be able to:
1 Pigmentary Disorders and Keloids
2 Define and discuss the pathogenesis, diagnosis, and treatment of pigmentary disorders, including vitiligo.
3 Define and discuss the pathogenesis, diagnosis, and treatment of keloids and hypertrophic scarring.
4 Illustrate how keloids and pigmentary disorders have psychological, socioeconomic, and cultural impact, and increased health disparities in people of color.
5 Summarize global scientific literature on research and newer therapeutic options in pigmentary disorders.

Moderator: Pearl E. Grimes, MD
Panelists: Seemal R. Desai, MD, FAAD, and Donald A. Glass II, MD, PhD

Technical Prerequisites

Please download and install Zoom app on your phone or desktop:

Coming session Starts Nov 18, 2020
Ends Nov 17, 2021